Hormone therapy did not increase mortality in postmenopausal women treated for early-stage estrogen receptor–positive breast cancer, but there was a recurrence risk with vaginal estrogen therapy.
MDedge News
Hormone Therapy Risk in Postmenopausal ER+ Breast Cancer
